Latest Resources

14 May 2010

A good neighbour? South Africa forcing GM maize onto African markets and policy makers

Since the beginning of 2010, South Africa’s Executive Council responsible for GMO permit approvals has granted export permits for almost 300,000 Metric Tons (MT) of GM maize to be exported to Kenya, Mozambique, and Swaziland collectively, and 35,000 MT of GM soybean to Mozambique.1 Despite South Africa being Africa’s largest producer of maize, and a […]

12 April 2010

GM Sugarcane: A long way from commercialisation?

Despite the best part of a decade of research and field trials, genetically modified sugar cane in South Africa remains a long way from commercial cultivation. Numerous research projects are currently underway at a number of publicly and privately funded research bodies, most of which are concentrating on increased sucrose and biomass content. Late last […]

11 June 2009

COMMENTS ON THE NATIONAL BIOTECHNOLOGY SAFETY BILL OF UGANDA

We have in the past, commented on several drafts of Uganda’s biosafety law and will not repeat the issues canvassed therein regarding the role and influence of the United States. We have been requested by civil society groups to comment on the National Biotechnology Safety Bill, 2008, approved by Uganda’s Cabinet during April 2008. Uganda […]

11 February 2007

Uganda – GMO Legislation

INTRODUCTION During 2001, Uganda embarked on a national agricultural biotechnology programme focusing on the several transformative biotechnology innovations, and genetic engineering (GE). This programme is linked to Uganda’s policy to eradicate poverty by 2015, described in its Poverty Eradication Action Plan (PEAP). PEAP is Uganda’s overarching macro-economic framework, designed to transform Uganda into a modern […]

11 May 2006

Mozambique – GMO Legislation

The proposed biosafety regulatory regime (hereafter referred to as the “draft biosafety law” or “biosafety law”) of the Republic of Mozambique consists of a draft Decree of Council of Ministers, containing the biosafety regulation and 2 draft technical guidelines for risk evaluation as well as public awareness and participation in biosafety and biotechnology related issues. […]